menu
    • menu

    Company profile for Oxurion

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oxurion is a biopharmaceutical company that has engineered a diverse portfolio of disease-modifying drug candidates, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. Oxurion owns the global rights to Jetrea (ocriplasmin), the only pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular tracti...
    Oxurion is a biopharmaceutical company that has engineered a diverse portfolio of disease-modifying drug candidates, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide. Oxurion owns the global rights to Jetrea (ocriplasmin), the only pharmacological vitreolysis drug approved for the treatment of symptomatic vitreomacular adhesion (in the U.S.) and vitreomacular traction (outside the U.S.). Oxurion is headquartered in Leuven, Belgium, and is listed on Euronext Brussels under the symbol OXUR.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OxurionBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Gaston Geenslaan 1 B-3001 Leuven
    Telephone
    Telephone
    +32 16 75 13 10
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oxurion.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oxurion2
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/oxurion

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oxurion Share Consolidation
    Oxurion Share Consolidation

    25 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/25/2919042/0/en/Oxurion-Share-Consolidation.html

    GLOBENEWSWIRE
    25 Jul 2024
    Share Share
    Oxurion Announces Results Of July 24 Extraordinary General Meeting
    Oxurion Announces Results Of July 24 Extraordinary General Meeting

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2918248/0/en/Oxurion-Announces-Results-on-the-Extraordinary-General-Meeting-EGM-of-24-July-2024.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Total Voting Rights Update Following Atlas Conversion Notice
    Total Voting Rights Update Following Atlas Conversion Notice

    19 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/19/2915996/0/en/Information-on-the-Total-Number-of-Voting-Rights-Denominator-following-Conversion-Notice-from-Atlas.html

    GLOBENEWSWIRE
    19 Jul 2024
    Share Share
    Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
    Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

    18 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/18/2915505/0/en/Oxurion-Receives-Transparency-Notification-from-Atlas-Special-Opportunities-LLC.html

    GLOBENEWSWIRE
    18 Jul 2024
    Share Share
    Oxurion Clarifies Agenda For July 24 Extraordinary Shareholders' Meeting
    Oxurion Clarifies Agenda For July 24 Extraordinary Shareholders' Meeting

    11 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/11/2912006/0/en/Oxurion-provides-clarification-on-the-agenda-of-the-extraordinary-general-shareholders-meeting-to-be-held-on-24-July-2024.html

    GLOBENEWSWIRE
    11 Jul 2024
    Share Share
    Oxurion signs a Letter of Intent acquire a French CRO in stem cell production
    Oxurion signs a Letter of Intent acquire a French CRO in stem cell production

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909872/0/en/Oxurion-signs-a-Letter-of-Intent-and-enters-into-exclusive-negotiations-to-potentially-acquire-a-pioneering-French-CRO-in-stem-cell-production.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search